naftopidil has been researched along with Bladder Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JI; Hong, JH; Jung, TY; Kang, TW; Kwak, C; Kwon, SY; Lee, JY; Lee, KS; Seo, SI; Yoo, TK; Yun, SJ | 1 |
| Dimitriadis, F; Kinoshita, Y; Ohmasa, F; Oikawa, R; Saito, M; Satoh, K; Shimizu, S; Tsounapi, P | 1 |
1 trial(s) available for naftopidil and Bladder Diseases
| Article | Year |
|---|---|
Comparison of the Effect of Naftopidil 75 mg and Tamsulosin 0.2 mg on the Bladder Storage Symptom With Benign Prostatic Hyperplasia: Prospective, Multi-institutional Study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases | 2018 |
1 other study(ies) available for naftopidil and Bladder Diseases
| Article | Year |
|---|---|
Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Body Weight; Circadian Rhythm; Indoles; Male; Muscle Contraction; Naphthalenes; Organ Size; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar; Urinary Bladder; Urinary Bladder Diseases; Urination | 2013 |